Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...

According to new research announced today, the fragile X syndrome (FXS) market across the USA and Germany is projected to ...

a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused autism ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...

a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused autism ...

US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...

Interestingly, the results suggest that a scheduled feeding approach could improve sleep and circadian rhythms while enhancing social interactions and reducing repetitive behaviors in a mouse model of ...